132 related articles for article (PubMed ID: 9731076)
1. Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history.
Mauser-Bunschoten EP; Damen M; Zaaijer HL; Sjerps M; Roosendaal G; Lelie PN; Cuypers HT; van den Berg HM
Blood; 1998 Sep; 92(6):2164-8. PubMed ID: 9731076
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
3. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.
Toyoda H; Takahashi I; Fukuda Y; Hayakawa T; Takamatsu J
J Med Virol; 2000 Jan; 60(1):34-8. PubMed ID: 10568760
[TBL] [Abstract][Full Text] [Related]
4. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
[TBL] [Abstract][Full Text] [Related]
5. High rates of hepatitis G virus infection in multitransfused patients with hemophilia.
De Filippi F; Colombo M; Rumi MG; Tradati F; Prati D; Zanella A; Mannucci PM
Blood; 1997 Dec; 90(11):4634-7. PubMed ID: 9373276
[TBL] [Abstract][Full Text] [Related]
6. GB virus-C/hepatitis G virus infection in a hepatitis C virus endemic village: prevalence in residents with low educational attainment and frequent recovery in females.
Cheng PN; Chang TT; Yang MH; Hu SC; Young KC; Wu HL; Jen CM; Ko AW; Lu SC
Liver; 2000 Jun; 20(3):222-7. PubMed ID: 10902972
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
[TBL] [Abstract][Full Text] [Related]
8. Natural course of HGV infection in haemophiliacs.
Yamada-Osaki M; Sumazaki R; Kajiwara Y; Miyakawa T; Shirahata A; Matsui A
Br J Haematol; 1998 Jul; 102(2):616-21. PubMed ID: 9695982
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
[TBL] [Abstract][Full Text] [Related]
10. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
[TBL] [Abstract][Full Text] [Related]
11. HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.
Fabris P; Biasin MR; Infantolino D; Romanó L; Benedetti P; Tositti G; Pellizzer GP; Zanetti AR; Stecca C; Marchelle G; de Lalla F
Infection; 1998; 26(5):283-7. PubMed ID: 9795785
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
Desassis JF; Laperche S; Girault A; Kolko A; Bouchardeau F; Zins B; Poignet JL; Couroucé AM
Nephrol Dial Transplant; 1999 Nov; 14(11):2692-7. PubMed ID: 10534514
[TBL] [Abstract][Full Text] [Related]
15. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.
Nordbø SA; Krokstad S; Winge P; Skjeldestad FE; Dalen AB
J Clin Microbiol; 2000 Jul; 38(7):2584-90. PubMed ID: 10878048
[TBL] [Abstract][Full Text] [Related]
17. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
[TBL] [Abstract][Full Text] [Related]
18. [Determination of hepatitis G virus markers in various risk groups].
Novikov DV; Pimenov VK; Samokhvalov EI; Mokhonov VV; Kolobov AA; Kopnina EO; Matveeva EM; Kuzin SN; Shatalov AG; Prilipov AG; Selivanov NA; L'vov DK
Vopr Virusol; 2000; 45(6):20-2. PubMed ID: 11200640
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-associated or nosocomial hepatitis G virus infection in patients undergoing surgery.
Lunel F; Frangeul L; Chuteau C; Fretz C; Thiers V; Azar N; Bidet JM; Huraux JM; Bréchot C; Valla D; Opolon P
Transfusion; 1998; 38(11-12):1097-103. PubMed ID: 9838943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]